Cryo-Save Group N.V. - Appointment of Ms. Karin Dorrepaal as Non-Executive Director
(Thomson Reuters ONE) -
Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading
international stem cell storage company and the largest family stem cell bank in
Europe, is happy to welcome Ms. Karin Dorrepaal, PhD, MBA as its new Non-
Executive Director.
Ms. Dorrepaal has been appointed at Cryo-Save's Annual General Meeting held on
May 16, 2012.
After obtaining her PhD in medicine at the Free University of Amsterdam on a
study executed in the Netherlands Cancer Institute and earning an MBA, she
joined Booz Allen & Hamilton (now Booz & Co.) to become Vice President focusing
on the pharmaceutical industry and advising clients on issues regarding
strategy, sales, marketing and supply chain. Subsequently she served on the
Executive Board of Schering AG in Berlin, where she was responsible for the
Diagnostic Imaging business (turnover EUR 1,3 billion) as well as for supply
chain and procurement. With her broad experience and strong external network
within the industry, Ms. Dorrepaal will be a valuable addition to the Cryo-Save
Board of Directors.
Ms. Dorrepaal served as a Non-Executive Director on the corporate boards of Ergo
Versicherungsgruppe AG and the Hogeschool van Amsterdam/ University of
Amsterdam. Currently she serves as a Non-Executive Director of MDxHealth SA in
Belgium, as a member of the Triton Private Equity Industry Board in Frankfurt
and as a member of the Supervisory Board of Gerresheimer AG in Düsseldorf.
Arnoud van Tulder, Chief Executive Officer, commented: "I am very glad to
welcome Ms. Dorrepaal as a new Non-Executive Director. Her solid international
experience will be an important asset to the Board in its continuous guidance
and supervision of the strategic development of Cryo-Save."
Enquiries:
Cryo-Save Group + 31 (0) 575 548 998
Arnoud van Tulder, Chief Executive Officer
SPJ Financiële Communicatie (The Netherlands) +31 (0)20 647 8181
Kees Jongsma/Leon Melens
Daniel Stewart & Company plc (UK) + 44 (0) 20 7776 6550
Martin Lampshire
College Hill (UK) + 44 (0) 20 7457 2020
Rozi Morris/ Adrian Duffield
Free footage is available on www.videobankonline.com
About Cryo-Save (www.cryo-save.com/group)
Cryo-Save, the leading international family stem cell bank, stores more than
200,000 samples from umbilical cord blood, cord tissue and adipose tissue. There
are already many diseases treatable by the use of stem cells, and the number of
treatments will only increase. Driven by its international business strategy,
Cryo-Save is now represented in over 40 countries on 3 continents, with ultra-
modern processing and storage facilities in Belgium, Germany, Dubai, India,
South Africa and France (validation in progress).
Click here for full press release in PDF:
http://hugin.info/143308/R/1613603/513882.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Cryo-Save Group N.V. via Thomson Reuters ONE
[HUG#1613603]
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
" alt="Northern Freegold Appoints Paul Reynolds Vice President, ExplorationDatum: 22.05.2012 - 07:00 Uhr
Sprache: Deutsch
News-ID 148630
Anzahl Zeichen: 3872
contact information:
Town:
Zutphen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 239 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Cryo-Save Group N.V. - Appointment of Ms. Karin Dorrepaal as Non-Executive Director"
steht unter der journalistisch-redaktionellen Verantwortung von
Cryo-Save Group N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
